Reduction in exacerbations with itepekimab in former smokers with chronic obstructive pulmonary disease (COPD) by prior exacerbation frequency

被引：0

作者：

Rabe, Klaus F. ^{[1
,2
]}

Christenson, Stephanie A. ^{[3
]}

Bourdin, Arnaud ^{[4
]}

Singh, Dave ^{[5
]}

Hanania, Nicola ^{[6
]}

Praestgaard, Amy ^{[7
]}

Soler, Xavier ^{[8
]}

Djandji, Michel ^{[7
]}

Deniz, Yamo

Rowe, Paul J. ^{[9
]}

Sacks, Harry ^{[7
]}

Jacob-Nara, Juby ^{[9
]}

机构：

[1] Airway Res Ctr North ARCN, Lungen Clin, Grosshansdorf, Germany

[2] German Ctr Lung Res DZL, Grosshansdorf, Germany

[3] Univ Calif San Francisco, Div Pulm Crit Care Allergy & Sleep Med, San Francisco, CA USA

[4] Univ Montpellier, Dept Resp Dis, Montpellier, France

[5] Manchester Univ NHS Fdn Trust, Univ Manchester, Med Evaluat Unit, Manchester, England

[6] Baylor Coll Med, Dept Med, Sect Pulm & Crit Care Med, Houston, TX USA

[7] Sanofi, Cambridge, MA USA

[8] Regeneron Pharmaceut Inc, Tarrytown, NY USA

[9] Sanofi, Bridgewater, NJ USA

来源：

EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷

关键词：

D O I：

10.1183/13993003.congress-2024.OA3645

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页数：3

共 50 条

[1] Respiratory Viruses in Smokers and Former Smokers with Exacerbations of Chronic Obstructive Pulmonary Disease
Drago, L.
De Vecchi, E.
Airoldi, A.
Mattina, R.
Papazian, B.
Legnani, D.
JOURNAL OF CHEMOTHERAPY, 2009, 21 (04) : 458 - 460
[2] The costs of exacerbations in chronic obstructive pulmonary disease (COPD)
Andersson, F
Borg, S
Jansson, SA
Jonsson, AC
Ericsson, Å
Prütz, C
Rönmark, E
Lundbäck, B
RESPIRATORY MEDICINE, 2002, 96 (09) : 700 - 708
[3] Treatment of exacerbations of chronic obstructive pulmonary disease (COPD)
Harrow, EM
Oldenburg, F
Blum, J
Shortall, S
Branscomb, J
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A813 - A813
[4] Exacerbation of Chronic Obstructive Pulmonary Disease Exacerbations in the Setting of Wildfires
Sivanandham, R.
Hussain, M.
Bagheri, S.
Barsoum, A.
Lee, D.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[5] Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study
Truedsson, Mikael
Malm, Johan
Sahlin, K. Barbara
Bugge, May
Wieslander, Elisabet
Dahlback, Magnus
Appelqvist, Roger
Fehniger, Thomas E.
Marko-Varga, Gyorgy
CLINICAL AND TRANSLATIONAL MEDICINE, 2016, 5
[6] . Evaluation of antibiotic management in the reduction of recurrent chronic obstructive pulmonary disease (COPD) exacerbations
Hunt, Laura
Lancaster, Jason
O'Gara, Elizabeth
Mitchell, Leslie
Balaguera, Henri
Liesching, Timothy
Lei, Yuxiu
PHARMACOTHERAPY, 2015, 35 (11): : E284 - E284
[7] Serum lysophosphatidic acid levels and exacerbation frequency in chronic obstructive pulmonary disease (COPD)
Li, Qingling
Birnberg, Andrew
Chakrabarti, Arindam
Choy, David
Verschueren, Erik
Neighbors, Margaret
Sandoval, Wendy
Rosenberger, Carrie
Grimbaldeston, Michele
Tew, Wei
EUROPEAN RESPIRATORY JOURNAL, 2020, 56
[8] Antibiotics for acute exacerbations of chronic obstructive pulmonary disease (COPD)
Burgel, P. -R.
MEDECINE ET MALADIES INFECTIEUSES, 2006, 36 (11-12): : 706 - 717
[9] Therapeutic Approaches for Chronic Obstructive Pulmonary Disease (COPD) Exacerbations
Rosenwasser, Yehudis
Berger, Irene
Loewy, Zvi G.
PATHOGENS, 2022, 11 (12):
[10] Antibiotic Therapy for Exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
Butorac-Petanjek, B.
Parnham, M. J.
Popovic-Grle, S.
JOURNAL OF CHEMOTHERAPY, 2010, 22 (05) : 291 - 297

← 1 2 3 4 5 →